Start Codon closes new £15 million venture fund to translate life science innovation into successful companies
Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP at £15 million ($20 million USD). The Fund will be used to support Start Codon’s offering to start-ups, which includes a minimum of £250K seed funding, business support services, expert guidance, and access to cutting-edge office and lab facilities.
Congenica completes $50m Series C funding round to advance clinical genomic analysis software and data platform
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the completion of its Series C funding round, raising US$50m (£39m).
Cambridge Innovation Capital results reflect 'tremendous progress'
Cambridge Innovation Capital plc (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, today announces highlights from its annual results for the year ended 31 March 2020.
CIC portfolio company Inivata announces strategic collaboration and investment from NeoGenomics
Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, is pleased to note that portfolio company Inivata, a leader in liquid biopsy, has today announced the formation of a strategic collaboration with NeoGenomics, Inc (NASDAQ: NEO), for the commercialisation of its InVisionFirst®-Lung liquid…
Exvastat receives grant to fund clinical study of existing drug in COVID-19 treatment
Exvastat (Ireland) Ltd, a privately held biopharmaceutical company backed by Cambridge Innovation Capital, announced the Innovative Medicines Initiative has awarded the company a €3.6m grant, following its call for developers to uncover a new use of the licensed drug therapy imatinib for the treatment of Acute Respiratory Distress Syndrome (ARDS) induced by COVID-19.
Inivata launches RaDaR™ for the detection of residual disease and recurrence
Inivata, a Cambridge Innovation Capital portfolio company and a leader in liquid biopsy, announces the availability of RaDaR™, an assay for the detection and monitoring of residual disease and recurrence in the plasma samples of patients previously diagnosed with cancer.
Carol Cheung promoted to Principal at Cambridge Innovation Capital
Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, is delighted to announce that Carol Cheung has been promoted to Principal within the CIC investment team.
CIC participates in $8.5 million Series A funding round in AudioTelligence
AudioTelligence, the company dedicated to making speech clear and intelligible in a noisy world, today announces that it has raised a further $8.5 million (£6.5 million) in Series A funding. The round was led by Octopus Ventures, with participation from existing investors Cambridge Innovation Capital, Cambridge Enterprise, and CEDAR Audio.
Cambridge Innovation Capital attracts £1 billion of investment into Cambridge companies
Since its foundation, Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies, highlighting its dominant position at the heart of the innovation ecosystem.
Sense Biodetection raises £12.3m to progress instrument-free molecular diagnostics
Sense Biodetection Limited (Sense) developers of simple, ultra-rapid, handheld tests for flu and other infectious diseases has raised £12.3M, in a funding round led by Cambridge Innovation Capital, with participation from Jonathan Milner.
CIC participates in CMR Surgical’s £195 million ($240 million) Series C financing
Cambridge Innovation Capital (CIC) takes part in Europe’s largest private financing round in the medical technology sector.
CIC participates in Gyroscope Therapeutics’s £50.4 million Series B funding
Cambridge Innovation Capital plc (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has participated in the £50.4 million Series B funding of Gyroscope Therapeutics, a company developing gene therapies and surgical delivery systems for retinal diseases, alongside lead investor Syncona Ltd.
CIC participates in PredictImmune’s £10 million Series B funding round
Cambridge Innovation Capital plc (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has participated in a £10 million Series B funding round in PredictImmune, a developer of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases.
CIC leads £3.25 million seed financing in quantum computing software developer Riverlane
Cambridge Innovation Capital plc (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has led a £3.25 million seed round in Riverlane, a quantum computing software developer transforming the discovery of new materials and drugs.
CIC participates in Audio Analytic’s $12 million funding round
Cambridge Innovation Capital plc (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has participated in the $12 million Series B funding round completed by Audio Analytic, the pioneer of sound recognition.
Dr Sohaib Mir promoted to Principal at Cambridge Innovation Capital
Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, is delighted to announce that Dr Sohaib Mir has been promoted to Principal within the Investment Team.
CIC co-founds Start Codon to deliver life science business acceleration programme
Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, announces the launch of Start Codon, a new strategic initiative aimed at driving the translation of world-class research into commercially successful companies, in which it is a founding investor.
Cambridge Innovation Capital announces the departure of its CEO
Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, announces the departure of its Chief Executive Officer, Victor Christou, following the successful completion of the recent fundraising.
Cambridge Innovation Capital raises £150 million of new capital
Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, has completed a funding round of £150 million, bringing the total amount of capital raised to date to £275 million.
CIC invests in Inivata’s £40 million series B funding round
Cambridge Innovation Capital plc (CIC), the venture capital investor focused on IP-rich technology and life science businesses in the Cambridge ecosystem, has participated in Inivata’s Series B fundraising of £40 million ($53 million). The first close of the financing occurred in August 2018, with the final tranche of the over-subscribed round being received in March 2019, based on strong…
CIC invests in Gyroscope Therapeutics
Cambridge Innovation Capital (CIC) has made an investment in Gyroscope Therapeutics (Gyroscope). Gyroscope is developing cutting edge, genetically defined therapies for the treatment of eye diseases linked to an unbalanced complement system, which is a part of the immune system.
CIC leads PragmatIC’s latest funding round
Cambridge Innovation Capital has led the latest funding round for PragmatIC, a world leader in ultra-low cost flexible electronics, raising a further investment of over £13 million. This investment, from existing and new investors, will enable PragmatIC to continue to increase production of its flexible integrated circuits (FlexICs).
CIC participates in Imagen’s £6.5 million Series B funding round
Cambridge Innovation Capital (CIC) has participated in a £6.5 million Series B funding for Imagen, the leading Software as a Service (SaaS) video management platform business.
Cambridge Innovation Capital leads AudioTelligence’s seed funding
Cambridge Innovation Capital has led a £3.1 million seed funding round into AudioTelligence Limited, a company delivering real-time audio processing technology for the enhancement of Automatic Speech Recognition (ASR) systems.
CIC leads $10 million Series B funding in SWIM.Al
Funding will fuel growth in this US-based edge computing business to launch an R&D centre in Cambridge, UK and accelerate development to meet growing demand for SWIM EDX software